Cytoplasmic Hu-Antigen R (HuR) Expression is Associated with Poor Survival in Patients with Surgically Resected Cholangiocarcinoma Treated with Adjuvant Gemcitabine-Based Chemotherapy
Crossref DOI link: https://doi.org/10.1245/s10434-018-6392-y
Published Online: 2018-02-28
Published Print: 2018-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Toyota, Kazuhiro
Murakami, Yoshiaki
Kondo, Naru
Uemura, Kenichiro
Nakagawa, Naoya
Takahashi, Shinya
Sueda, Taijiro
Text and Data Mining valid from 2018-02-28
Article History
Received: 15 November 2017
First Online: 28 February 2018